Clinical trials recruiting for Von Hippel-Lindau Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 68-Gallium DOTATATE | 1 |
| Belzutifan | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 2 |
| Tennessee | 2 |
| California | 1 |
| Illinois | 1 |
| Iowa | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Missouri | 1 |
| New York | 1 |
| Pennsylvania | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Familial Investigations of Childhood Cancer Predisposition
- Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
- Institutional Registry of Rare Diseases
- Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Related conditions
Trials recruiting for Von Hippel-Lindau Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Von Hippel-Lindau Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.